Viyash Scientific Limited (NSE:VIYASH)
India · Delayed Price · Currency is INR 213.58
-7.53 (-3.41%)
Oct 21, 2026, 3:30 PM IST
Viyash Scientific Market Cap
Viyash Scientific has a market cap or net worth of 93.51 billion as of October 21, 2026. Its market cap has increased by 87.43% in one year.
Market Cap
93.51B
Enterprise Value
97.85B
Revenue
35.75B
Global Rank
n/a
Country Rank
n/a
PE Ratio
44.25
ChartMarket Cap Chart
Since January 5, 2005, Viyash Scientific's market cap has increased from 347.75M to 93.51B, an increase of 26,790.64%. That is a compound annual growth rate of 29.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 93.51B | 3.11% |
| Dec 31, 2025 | 90.70B | 106.22% |
| Dec 31, 2024 | 43.98B | 55.47% |
| Dec 29, 2023 | 28.29B | 29.89% |
| Dec 30, 2022 | 21.78B | -45.17% |
| Dec 31, 2021 | 39.72B | -4.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cohance Lifesciences | 175.11B |
| Alivus Life Sciences | 155.71B |
| Eris Lifesciences | 155.44B |
| Alembic Pharmaceuticals | 155.35B |
| NATCO Pharma | 143.44B |
| Sudeep Pharma | 113.32B |
| Akums Drugs and Pharmaceuticals | 108.63B |
| Strides Pharma Science | 94.87B |